SAN FRANCISCO--(BUSINESS WIRE)--Elation Health, the clinical-first technology company powering innovation in primary care, today announced that Seth Cedars has joined the company as general counsel and Tom Natt joined as chief growth officer. In these roles, Cedars and Natt will apply their deep healthcare, technology, and digital health experience to Elation’s continued customer and market expansion. In the past year, Elation has added over 600 customers, including expanding support of enterprise organizations and developers. The company currently supports 30,000 primary-care-first clinicians delivering high-value care to more than 12 million Americans.
“Welcoming Tom and Seth to the Elation leadership team supports our continued work to facilitate and elevate the delivery of primary care in any setting,” said Kyna Fong, Ph.D., co-founder and CEO of Elation Health. “When primary care clinicians are able to sustainably and effectively deliver care, patients benefit from stronger clinician relationships, the highest-quality personalized care, and better health outcomes. Tom and Seth are essential to our strategy to ensure that primary care clinicians are supported through Elation’s platform.”
Seth Cedars, general counsel – Cedars brings to Elation nearly two decades of corporate legal, regulatory, licensing, and compliance leadership. Cedars was previously deputy general counsel at tech startup Capella Space and spent the previous nine years at Healthgrades, the leading online marketplace for consumers to find and connect with the right doctor, hospital, and care, serving as general counsel and privacy officer where he led legal and compliance activities. He joins Elation as general counsel, where he is responsible for working alongside the executive team, providing advice on a variety of legal and business aspects, as well as supporting the team to maintain a culture that combines the highest standards of integrity with responsive, practical approaches.
Tom Natt, chief growth officer – With a two-decade track record of success and leadership in healthcare, Natt brings extensive, proven digital health and commercial growth experience to the role. Prior to joining Elation, Natt was the vice president of growth strategy and new market development of connectRN, a nurse-centric employment platform; served as the head of sales for Firefly Health, a digital health company; and had a 13-year tenure with athenahealth, where he spearheaded substantial growth leading its Independent Medical Group and Independent Healthcare Enterprise segments. Natt is responsible for supporting customers and growing sales impact, as well as driving revenue operations for the primary care-focused EHR platform. He oversees the expansion of Elation’s market-leading EHR, utilized by clinicians in hundreds of practices across 50 states, as well as Elation’s Billing software and additional product lines.
Powering the largest network of independent primary care, Elation’s focus on a clinical-first design approach respects, rather than disrupts, the sanctity of the physician-patient relationship. Whether innovating through new payment transactions such as with CMS’s alternative payment models, Direct Primary Care (DPC), or new delivery platforms from leading startups, Elation gives care teams the tools necessary to create the tremendous value that only primary care can deliver.
About Elation Health
Elation Health is the most trusted technology platform for high-value primary care. Since 2010, the company has delivered clinical-first solutions — built on a collaborative EHR platform — that help primary care organizations start, grow, and succeed in delivering the highest-quality personalized care to patients. Elation supports the mission of primary care by providing technology solutions that ease burden and allow physicians to focus on caring for their patients. The company serves 30,000 clinicians caring for more than 12 million Americans, including thousands of small independent practices and large prominent digital health innovators. Elation Health is looking ahead to another year of advancement after securing $50 million in Series D funding in 2022, with plans to continue investing in technology and services as it rapidly scales. Learn more at elationhealth.com, LinkedIn, and X.
